GlassScriptPhysician profile
Jonathan T Scott
NPI 1326224254
$2,861.60
in general payments reported to CMS, 2019-2025
28 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $367 · 2021: $477 · 2022: $406 · 2023: $390 · 2024: $357 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $748.12 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Astellas Pharma US INC | $422.55 | 2019-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $269.12 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Coolseal Generator |
| Pfizer INC. | $235.70 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $212.64 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $145.18 | 2022-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $114.25 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $109.17 | 2021-2023 | |
| Therapeuticsmd, INC. | $74.37 | 2019-2022 | |
| Coloplast Corp | $74.35 | 2020-2025 | |
| Amgen INC. | $69.39 | 2019-2025 | Evenity |
| Sage Therapeutics, LLC | $40.12 | 2024-2025 | Zurzuvae |
| Urovant Sciences INC | $37.12 | 2022 | |
| Myovant Sciences INC. | $35.76 | 2021-2022 | |
| Duchesnay USA Incorporated | $34.64 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $29.09 | 2022-2023 | Nexplanon |
| Solventum Corporation | $24.51 | 2025 | Prevena |
| Conmed Corporation | $22.15 | 2023 | Airseal |
| Davol INC. | $21.90 | 2020 | |
| Radius Health, INC. | $20.25 | 2020 | |
| Alexion Pharmaceuticals, INC. | $19.00 | 2019 | |
| Medline Industries LP | $16.78 | 2025 | |
| Merck Sharp & Dohme LLC | $15.98 | 2019 | |
| Shield Therapeutics INC | $15.58 | 2024 | |
| Scynexis, INC. | $14.29 | 2022 | |
| Lupin INC. | $13.78 | 2019 | |
| Medtronic, INC. | $13.76 | 2021 | |
| Agile Therapeutics, INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.